- Altman G D, Bland M J. How to randomise. BMJ 1999a; 319: 703–4
- Altman D G, Bland M J. Statistics notes. Treatment allocation in controlled trials: why randomise?. BMJ 1999b; 318: 1209
- Bhandari M, Haynes B R. How to appraise the effectiveness of treatment. World J Surg 2005; 29: 570–5
- Bhandari M, Sanders W R. Wher's the evidence? Evidencebased orthopaedic trauma: a new section in the Journal. J Orthop Trauma 2003; 17: 87
- Bhandari M, Guyatt H G, Swiontkowski F M. User's guide to the orthopaedic literature: how to use an article about a surgical therapy. J Bone Joint Surg (Am) 2001; 83: 916–26
- Bhandari M, Whang W, Kuo C J, Devereaux J P, Sprague S, Tornetta P, III. The risk of false-positive results in orthopaedic surgical trials. Clin Orthop 2003; 413: 63–9
- Bhandari M, Montori M V, Schemitsch H E. The undue influence of significant p-values on the perceived importance of study results. Acta Orthop 2005; 76: 291–5
- Bhandari M, Devereaux J P, Li P, Mah D, Lim K, Schunemann J H, Tornetta P, III. Misuse of baseline comparison tests and subgroup analyses in surgical trials. Clin Orthop 2006; 447: 247–51
- Black M D, Cummings R S, Karpf B D, Cauley A J, Thompson E D, Nevitt C M, Bauer C D, Genant K H, Haskell L W, Marcus R, Ott M S, Torner C J, Quandt A S, Reiss F T, Ensrud E K. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 348: 1535–41
- Black M D, Schwartz V A, Ensrud E K, Cauley A J, Levis S, Quandt A S, Satterfield S, Wallace B R, Bauer C D, Palermo L, Wehren E L, Lombardi A, Santora C A, Cummings S R. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 2006; 296: 2927–38
- Bland M J, Altman G D. Statistics notes: Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170
- Boutron I, Tubach F, Giraudeau B, Ravaud P. Blinding was judged more difficult to achieve and maintain in nonphar macologic than pharmacologic trials. J Clin Epidemiol 2004; 57: 543–50
- Boutron I, Moher D, Tugwell P, Giraudeau B, Poiraudeau S, Nizard R, Ravaud P. A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol 2005; 58: 1233–40
- Bryant D, Havey C T, Roberts R, Guyatt G. How many patients? How many limbs? Analysis of patients or limbs in the orthopaedic literature: A systematic review. J Bone Joint Surg (Am) 2006; 88: 41–5
- Busse W J, Heetveld J M. Critical appraisal of the orthopaedic literature: therapeutic and economic analysis. Injury 2006; 37: 312–20
- Chimento F G, Pavone V, Sharrock N, Kahn B, Cahill J, Sculco P T. Minimally invasive total hip arthroplasty: a prospective randomized study. J Arthroplasty 2005; 20: 139–44
- Colon-Emeric S C. Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing. JAMA 2006; 296: 2968–9
- Devereaux J P, Manns J B, Ghali A W, Quan H, Lacchetti C, Montori M V, Bhandari M, Guyatt H G. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 2001; 285: 2000–3
- Devereaux J P, Choi T P, El Dika S, Bhandari M, Montori M V, Schunemann J H, Garg X A, Busse W J, Heels-Ansdell D, Ghali A W, Manns J B, Guyatt H G. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol 2004; 57: 1232–6
- Dunkow D P, Jatti M, Muddu N B. A comparison of open and percutaneous techniques in the surgical treatment of tennis elbow. J Bone Joint Surg (Br) 2004; 86: 701–4
- Fergusson D, Aaron D S, Guyatt G, Hebert P. Post-ran-domisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002; 325: 652–4
- Guyatt H G, Rennie D. The Evidence-Based Medicine Working Group. Users' guides to the medical literature. A manual for evidence-based clinical practice. AMA press, Chicago 2002
- Hayward R. Centre for Health Evidence, http://www.cche net/2007
- Joshi B A, Gill S G, Smith L P. Outcome in patients lost to follow-up. J Arthroplasty 2003; 18: 149–53
- Juni P, Altman G D, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001; 323: 42–6
- Montori M V, Jaeschke R, Schunemann J H, Bhandari M, Brozek L J, Devereaux J P, Guyatt H G. Users' guide to detecting misleading claims in clinical research reports. BMJ 2004; 329: 1093–6
- Montori M V, Busse W J, Permanyer-Miralda G, Ferreira I, Guyatt H G. How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: should I dump this lump? ACP. J Club 2005a; 143: A8
- Montori M V, Permanyer-Miralda G, Ferreira-Gonzalez I, Busse W J, Pacheco-Huergo V, Bryant D, Alonso J, Akl A E, Domingo-Salvany A, Mills E, Wu P, Schunemann J H, Jaeschke R, Guyatt H G. Validity of composite end points in clinical trials. BMJ 2005b; 330: 594–6
- Moseley B J, O'Malley K, Petersen J N, Menke J T, Brody A B, Kuykendall H D, Hollingsworth C J, Ashton M C, Wray P N. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002; 347: 81–8
- Poolman W R, Kocher S M, Bhandari M. Pediatric femoral fractures: A systematic review of 2422 cases. J Orthop Trauma 2006; 20: 648–54
- Poolman W R, Struijs A P, Krips R, Sierevelt N I, Marti K R, Farrokhyar F, Bhandari M. Reporting of outcomes in orthopaedic randomized trials: does blinding of outcome assessors martter?. J Bone Joint Surg (Am) 2007; 89(3)550–8
- Pynsent B P. Choosing an outcome measure. J Bone Joint Surg (Br) 2001; 83: 792–4
- Richardson S W, Wilson C M, Nishikawa J, Hayward S R. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995; 123: A12–A13
- Sackett L D, Straus E S, Richardson S W, Rosenberg W, Haynes B R. Evidence-based medicine. Churchill Livingstone 2000
- Struijs P, Kerkhoffs G. Ankle sprain. Clin Evid 2006; 15: 1493–501
- Turpie G A, Fisher D W, Bauer A K, Kwong M L, Irwin W M, Kalebo P, Misselwitz F, Gent M. BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. J Thromb Haemost 2005; 3: 2479–86
- Wright G J, Swiontkowski F M. Introducing a new journal section: Evidence-based orthopaedics. J Bone Joint Surg (Am) 2000; 82: 759
- Zlowodzki D M M, Bhandari D M M, Brown M G A, Cole M P A, Swiontkowski M M F. Planning a randomized trial: Determining the study sample size. Tech Orthop 2004; 19: 72–6
- Zlowodzki M, Jonsson A, Bhandari M. Common pitfalls in the conduct of clinical research. Med Princ Pract 2006; 15: 1–8
Acta Orthopaedica
Volume 78, 2007 - Issue 2